Fengchao Y. Liu - Publications

Understanding how hypoxia contributes to liver cancer stem cells maintenance.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 25, 2026

Indole-3-lactic acid attenuates hepatic stellate cell pyroptosis and liver fibrosis associated with NLRP3 signaling.

Journal: Experimental cell research

Published: January 05, 2026

IGF1/IGF1R signaling promotes the expansion of liver CSCs and serves as a potential therapeutic target in HCC.

Journal: Discover oncology

Published: April 04, 2025

Mechanisms of CRLF3-targeted binding to ACTR2 to promote hepatocellular carcinoma progression and effects on the immune microenvironment.

Journal: Cytotechnology

Published: February 10, 2025

Biological roles and clinical applications of EpCAM in HCC.

Journal: Discover oncology

Published: December 05, 2024

Gracillin Protects Liver Ischemia-Reperfusion Injury from Oxidative Stress-Induced Apoptosis.

Journal: Drug design, development and therapy

Published: July 29, 2024

The role of IGF/IGF-1R signaling in the regulation of cancer stem cells.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 08, 2024